←Back to Expert Scholars
Translational Medicine / 转化医学Cord Blood Transplant, AML Outcomes
Daniel Weisdorf
MD
🏢University of Minnesota🌐USA
Professor of Medicine
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Daniel Weisdorf has led major comparative studies of cord blood versus matched donor HCT at Minnesota, a leading cord blood center. His work informs donor selection algorithms particularly in AML. He has mentored numerous HCT researchers.
Share:
🧪Research Fields 研究领域
AML transplant
cord blood outcomes
allogeneic HCT
CIBMTR analyses
older adult transplant
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Daniel Weisdorf 的研究动态
Follow Daniel Weisdorf's research updates
留下邮箱，当我们发布与 Daniel Weisdorf（University of Minnesota）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment